Internal Medicine, Endocrinology, Diabetes, & Metabolism · Madisonville, KY
NPI
1447498522
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
800 Hospital Dr
Madisonville, KY, 42431
Phone (270) 326-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
3,536 services
Medicare patients, 2024
412
Average age 71
Drug cost, 2024
$8.9M
12,576 prescriptions
Company payments, 2025
$113K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sergio Chang Figueroa was code 99214 (office e&m - established), 670 times for 380 patients. In total Sergio Chang Figueroa billed 3,536 services in 20 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 670 | 380 | $80.82 | $54K |
| 95251 Test - Miscellaneous | Office | 364 | 190 | $24.72 | $8,999 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 144 | 130 | $12.32 | $1,774 |
| 99204 Office E&M - New | Office | 34 | 34 | $98.84 | $3,361 |
| 82962 Clinical Chemistry | Office | 25 | 22 | $3.21 | $80.25 |
| 83036 Blood Count | Office | 24 | 21 | $9.52 | $228 |
By year: 2022 $94K for 1,381 services; 2023 $94K for 1,451 services; 2024 $76K for 3,536 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 25 | 22 | $3.21 | $80.25 |
| 83036 Blood Count | 24 | 21 | $9.52 | $228 |
Medicare prescription drug claims, 2024
In 2024, the drug Sergio Chang Figueroa prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 811 prescriptions and refills. In total Sergio Chang Figueroa wrote 12,576 Medicare prescriptions that cost $8.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 811 | 940 | 134 | $969K |
| Levothyroxine Sodium Generic | 715 | 1,651 | 171 | $6,540 |
| Ozempic Semaglutide | 634 | 906 | 137 | $858K |
| Jardiance Empagliflozin | 590 | 987 | 128 | $563K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 441 | 588 | 77 | $400K |
| Rosuvastatin Calcium Generic | 441 | 986 | 119 | $4,540 |
| Kerendia Finerenone | 411 | 671 | 86 | $422K |
| Gabapentin Generic | 329 | 389 | 61 | $3,301 |
| Xultophy 100-3.6 Insulin Degludec/Liraglutide | 321 | 415 | 64 | $494K |
| Metformin Hcl Er Metformin Hcl | 317 | 667 | 78 | $2,230 |
| Novolog Flexpen Insulin Aspart | 254 | 365 | 98 | $65K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 240 | 382 | 92 | $23K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 236 | 277 | 50 | $242K |
| Trulicity Dulaglutide | 208 | 323 | 52 | $311K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 200 | 338 | 40 | $186K |
Brand drugs: 6,680 claims; generic drugs: 4,686 claims; opioid claims: 69.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sergio Chang Figueroa $113K ($113K in general payments such as food, travel and fees) from 22 companies. The largest payer was Novo Nordisk Inc with $31K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 45 | $31K |
| Lilly USA, LLC LLY | 48 | $26K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 37 | $25K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 26 | $14K |
| Corcept Therapeutics CORT | 25 | $12K |
| Abbott Laboratories ABT | 6 | $1,751 |
| Medtronic, Inc. MDT | 23 | $818 |
| Mannkind Corporation MNKD | 21 | $389 |
| Insulet Corporation PODD | 13 | $188 |
| Amgen Inc. AMGN | 10 | $142 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.